Physician Directory

Text Size A A

E-Mail to a Friend






secret  Click to Play Audio


M. Juliana McElrath, MD, PhD

Dr. McElrath is an allergy and infectious diseases specialist at UW Medicine with research in protection and control of HIV-1 infection by T Cell immunity and infectious disease immunology.

Dr. McElrath's Resume


Title

  • Senior Vice President, VIDD; Member, Clinical Research Division, Fred Hutchinson Cancer Research Center
  • Professor, Department of Medicine, Global Health and Laboratory Medicine, University of Washington School of Medicine

Clinical Expertise

Protection and Control of HIV-1 Infection by T Cell Immunity, infectious disease Immunology

Experience

Dr. McElrath's research, conducted through the McElrath Lab, centers on developing an HIV vaccine and investigates the complex relationships between HIV and the immune system.

More specifically, Dr. McElrath investigates how components of T-cell immunity elicited early in HIV-1 infection contribute to control of HIV-1 disease, what the influence of antiretroviral therapy is, whether T-cell immune responses are involved in resistance to HIV-1 infection in high-risk persons, how antigen-specific mucosal T cells protect against HIV-1 exposure, and what elements of immunity correlate with protection against HIV-1 infection by vaccine.

Dr. McElrath has built and maintains an international HIV vaccine laboratory program, conducted translational immunological research in humans in a multicenter setting, contributed to our fundamental understanding of how HIV-1 enters the mucosa to establish infection, identified persons with very low levels of HIV DNA who otherwise lack all evidence of infection, assembled invaluable cohorts from which to elucidate mechanisms of risk for HIV infection and disease, and mentored junior faculty, young investigators, and graduate students.

She has assumed a leadership role or been a major contributor in a number of integrated programs at the national and international level to advance a coordinated effort to tackle the HIV epidemic through prevention efforts: the HIV Vaccine Trials Network (PI and Director of the Laboratory Program), the Gates Foundation Innate Immunity Consortium (PI), the Microbicide Trials Network (Director, Immunology Core) and the Seattle Vaccine Trials Unit (PI).

Education And Training

  • MD: Medical University of South Carolina, 1980
  • Internship and Residency: Internal Medicine, Medical University of South Carolina, 1980-1983
  • Fellowship: Infectious Diseases, Columbia Presbyterian Medical Center, N.Y., 1983-1985
  • Postdoctoral Fellow: Laboratory of Cellular Physiology and Immunology,
    Rockefeller University, N.Y., 1985-1988

More Information

For more information about Dr. M. Juliana McElrath's clinical and research expertise, click here.

Dr. McElrath's Story


Dr. McElrath's research, conducted through the McElrath Lab, centers on developing an HIV vaccine and investigates the complex relationships between HIV and the immune system.

More specifically, Dr. McElrath investigates how components of T-cell immunity elicited early in HIV-1 infection contribute to control of HIV-1 disease, what the influence of antiretroviral therapy is, whether T-cell immune responses are involved in resistance to HIV-1 infection in high-risk persons, how antigen-specific mucosal T cells protect against HIV-1 exposure, and what elements of immunity correlate with protection against HIV-1 infection by vaccine.

Dr. McElrath has built and maintains an international HIV vaccine laboratory program, conducted translational immunological research in humans in a multicenter setting, contributed to our fundamental understanding of how HIV-1 enters the mucosa to establish infection, identified persons with very low levels of HIV DNA who otherwise lack all evidence of infection, assembled invaluable cohorts from which to elucidate mechanisms of risk for HIV infection and disease, and mentored junior faculty, young investigators, and graduate students.

She has assumed a leadership role or been a major contributor in a number of integrated programs at the national and international level to advance a coordinated effort to tackle the HIV epidemic through prevention efforts: the HIV Vaccine Trials Network (PI and Director of the Laboratory Program), the Gates Foundation Innate Immunity Consortium (PI), the Microbicide Trials Network (Director, Immunology Core) and the Seattle Vaccine Trials Unit (PI).